mitomycin has been researched along with Primary Peritonitis in 23 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A new drug dosage form comprising activated carbon particles adsorbing mitomycin C (MMC-CH) is designed to slowly release its components, and has affinity for the tumor surface and lymph nodes and a tendency to stay long in the local portion." | 6.66 | Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials. ( Hagiwara, A; Itoh, T; Lee, R; Takahashi, T; Takeda, M; Ueda, T, 1987) |
| "A 71-year-old man with Borrmann type 3 gastric cancer and peritonitis carcinomatosa was treated with 5'-DFUR 600 mg/body p." | 5.30 | [Successful 5'-DFUR, CDDP and MMC combination therapy and 5'-DFUR and carboplatin combination therapy for a patient with inoperable advanced gastric cancer with peritonitis carcinomatosa]. ( Ando, S; Katanuma, A; Maekubo, H; Mori, M; Tsuji, K, 1997) |
| "A new drug dosage form comprising activated carbon particles adsorbing mitomycin C (MMC-CH) is designed to slowly release its components, and has affinity for the tumor surface and lymph nodes and a tendency to stay long in the local portion." | 2.66 | Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials. ( Hagiwara, A; Itoh, T; Lee, R; Takahashi, T; Takeda, M; Ueda, T, 1987) |
| "Treatment of advanced gastric cancers with peritonitis carcinomatosa is very difficult, because none of the various therapies (operation, chemotherapy, hyperthermia etc." | 1.32 | [A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites]. ( Doi, K; Horiuchi, T; Nakamura, T; Okubo, Y; Shimada, K; Tanabe, S; Tanaka, K; Tanaka, S; Uchinami, M; Yoshida, M, 2004) |
| "Diffuse pyogenic gelatinous ascites and a large cystic mass with a grayish wall, and a hard solid lesion in part were found." | 1.31 | Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case. ( Kuroki, Y; Otagiri, S; Tsukada, K, 2001) |
| "A 71-year-old man with Borrmann type 3 gastric cancer and peritonitis carcinomatosa was treated with 5'-DFUR 600 mg/body p." | 1.30 | [Successful 5'-DFUR, CDDP and MMC combination therapy and 5'-DFUR and carboplatin combination therapy for a patient with inoperable advanced gastric cancer with peritonitis carcinomatosa]. ( Ando, S; Katanuma, A; Maekubo, H; Mori, M; Tsuji, K, 1997) |
| "Eighty gastric cancer patients with peritoneal dissemination were analyzed to evaluate the effect of intraperitoneal chemo- and/or immunotherapy on abdominal ascites." | 1.30 | [Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination]. ( Kajiura, Y; Kondoh, Y; Makuuchi, H; Mitomi, T; Miyaji, M; Nakamura, K; Ogoshi, K; Tajima, T, 1997) |
| "Six patients with gastric cancer and two patients with colon cancer underwent these procedures." | 1.29 | [Chemohyperthermic peritoneal perfusion and subtotal peritonectomy for peritonitis carcinomatosa in gastroenteric cancer]. ( Fujimura, T; Fujita, H; Fushida, S; Hirono, Y; Itoh, H; Kaji, M; Kinami, S; Nakagawara, H; Nakai, M; Yonemura, Y, 1995) |
| " The dosage was 14 mg/m2 (7 mg/m2 at second and following administrations) of MMC and 35 mg/m2 of CDDP and they were repeatedly administered in the abdominal cavity via the drug delivery system." | 1.29 | [Intraperitoneal repeated chemotherapy using CDDP combined with MMC for carcinomatous peritonitis]. ( Arai, K; Kitamura, M; Miyashita, K, 1993) |
| " Pharmaceutical dosage was set at approximately 30% of the increased life span (ILS) for Meth-A." | 1.28 | [Experimental study of the treatment of carcinomatous peritonitis in gastric cancer]. ( Arai, K; Kitamura, M; Miyashita, K, 1992) |
| "Because the subjects studied were gastric cancer cases exceeding H2, the present investigation resulted in the increase of metastatic liver lesions, a problem to be studied in future." | 1.28 | [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis]. ( Hasegawa, Y; Honnma, S; Nakashima, Y; Takanashi, K; Yajima, K, 1991) |
| "The cases were comprised of 9 gastric cancers, 6 colorectal cancers, 1 appendiceal carcinoma, and 1 malignant tumor of retroperitoneum, all of which were observed to have peritoneal dissemination during surgical operations." | 1.28 | [Evaluation of intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa]. ( Katsuki, Y; Nishimura, A; Tsuji, Y; Yasuda, T, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.04) | 18.7374 |
| 1990's | 16 (69.57) | 18.2507 |
| 2000's | 4 (17.39) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamo, Y | 1 |
| Takeyama, H | 1 |
| Funahashi, H | 1 |
| Yamamori, Y | 1 |
| Yamamoto, M | 1 |
| Teranishi, F | 1 |
| Manabe, T | 1 |
| Aihara, H | 1 |
| Maruoka, H | 1 |
| Kiyozaki, H | 1 |
| Konishi, F | 1 |
| Nakamura, T | 1 |
| Shimada, K | 1 |
| Okubo, Y | 1 |
| Tanaka, S | 1 |
| Tanabe, S | 2 |
| Yoshida, M | 1 |
| Doi, K | 1 |
| Uchinami, M | 1 |
| Horiuchi, T | 1 |
| Tanaka, K | 1 |
| Takahashi, T | 2 |
| Hagiwara, A | 2 |
| Ito, T | 1 |
| Fujimura, T | 1 |
| Yonemura, Y | 1 |
| Nakagawara, H | 1 |
| Fujita, H | 1 |
| Itoh, H | 1 |
| Hirono, Y | 1 |
| Kinami, S | 1 |
| Kaji, M | 1 |
| Nakai, M | 1 |
| Fushida, S | 1 |
| Gallinaro, RN | 1 |
| Naziri, W | 1 |
| McMasters, KM | 1 |
| Peyton, JC | 1 |
| Cheadle, WG | 1 |
| Kitamura, M | 4 |
| Arai, K | 4 |
| Iwasaki, Y | 2 |
| Miyashita, K | 2 |
| Kosaka, T | 1 |
| Takano, Y | 1 |
| Nakano, Y | 1 |
| Akiyama, T | 1 |
| Kiriyama, M | 1 |
| Tomita, F | 1 |
| Saito, H | 1 |
| Kita, I | 1 |
| Takashima, S | 1 |
| Nakagawa, T | 1 |
| Matsui, R | 1 |
| Kashihara, K | 1 |
| Higashi, T | 1 |
| Seo, K | 1 |
| Taoka, Y | 1 |
| Yoshida, S | 1 |
| Nishitani, H | 1 |
| Takegawa, Y | 1 |
| Hukumura, Y | 1 |
| Ando, S | 2 |
| Katanuma, A | 1 |
| Mori, M | 1 |
| Tsuji, K | 1 |
| Maekubo, H | 1 |
| Kajiura, Y | 1 |
| Ogoshi, K | 1 |
| Nakamura, K | 1 |
| Miyaji, M | 1 |
| Kondoh, Y | 1 |
| Makuuchi, H | 1 |
| Tajima, T | 1 |
| Mitomi, T | 1 |
| Takayanagi, N | 1 |
| Danjo, Y | 1 |
| Kuroki, Y | 1 |
| Otagiri, S | 1 |
| Tsukada, K | 1 |
| Sugiyama, Y | 1 |
| Saji, S | 1 |
| Furuta, T | 1 |
| Azuma, S | 1 |
| Miya, K | 1 |
| Umemoto, T | 1 |
| Takao, H | 1 |
| Kato, M | 1 |
| Kanno, A | 1 |
| Konno, C | 1 |
| Fujimoto, S | 1 |
| Shrestha, RD | 1 |
| Kokubun, M | 1 |
| Kobayashi, K | 1 |
| Kiuchi, S | 1 |
| Takahashi, M | 1 |
| Ohta, M | 1 |
| Hasegawa, Y | 1 |
| Honnma, S | 1 |
| Takanashi, K | 1 |
| Yajima, K | 1 |
| Nakashima, Y | 1 |
| Yamada, Y | 1 |
| Nakatani, K | 1 |
| Watanabe, A | 1 |
| Sawada, H | 1 |
| Yano, T | 1 |
| Shino, Y | 1 |
| Nakano, H | 1 |
| Tsuji, Y | 1 |
| Nishimura, A | 1 |
| Katsuki, Y | 1 |
| Yasuda, T | 1 |
| Lee, R | 1 |
| Ueda, T | 1 |
| Takeda, M | 1 |
| Itoh, T | 1 |
| Ishibashi, H | 1 |
| Hirakawa, K | 1 |
| Nakajima, H | 1 |
| Ioka, J | 1 |
| Shirono, K | 1 |
| Ochiai, K | 1 |
| Tomita, K | 1 |
| Kitagawa, Y | 1 |
2 trials available for mitomycin and Primary Peritonitis
| Article | Year |
|---|---|
[Evaluation of intraperitoneal chemotherapy using CDDP combined with MMC in gastric carcinomatous peritonitis].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Fe | 1994 |
Chemotherapy for carcinomatous peritonitis and pleuritis with MMC-CH, mitomycin C adsorbed on activated carbon particles. Clinical trials.
Topics: Charcoal; Clinical Trials as Topic; Dosage Forms; Female; Humans; Microscopy, Electron; Middle Aged; | 1987 |
21 other studies available for mitomycin and Primary Peritonitis
| Article | Year |
|---|---|
[Efficacy of intraperitoneal chemotherapy for advanced Borrmann type IV gastric carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans; Infus | 2002 |
Sclerosing encapsulating peritonitis (SEP) as a delayed complication of continuous hyperthermic peritoneal perfusion (CHPP): report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; | 2003 |
[A case of advanced gastric cancer with peritonitis carcinomatosa resected with intraperitoneal chemotherapy based on chemosensitivity test with ascites].
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Ascitic Fluid; Cisplatin; Drug Administrati | 2004 |
[Intraabdominal administration of MMC adsorbed on activated carbon for management of carcinomatous peritonitis].
Topics: Abdomen; Carbon; Colonic Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Middle Aged; Mitomyc | 1984 |
[Chemohyperthermic peritoneal perfusion and subtotal peritonectomy for peritonitis carcinomatosa in gastroenteric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combined | 1995 |
Alteration of mononuclear cell immune-associated antigen expression, interleukin-1 expression, and antigen presentation during intra-abdominal infection.
Topics: Abdominal Abscess; Acetylmuramyl-Alanyl-Isoglutamine; Animals; Antigen Presentation; Flow Cytometry; | 1994 |
[Intraperitoneal repeated chemotherapy using CDDP combined with MMC for carcinomatous peritonitis].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administratio | 1993 |
[Intraarterial infusion chemotherapy for recurrent or unresectable gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluoroura | 1993 |
[A case of recurrent squamous cell carcinoma of cervix successfully treated with BOMP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Fema | 1996 |
[Successful 5'-DFUR, CDDP and MMC combination therapy and 5'-DFUR and carboplatin combination therapy for a patient with inoperable advanced gastric cancer with peritonitis carcinomatosa].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Drug Administration Sc | 1997 |
[Evaluation of intraperitoneal chemotherapy using CDDP/MMC or CDDP for gastric carcinomatous peritonitis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Humans; Inf | 1997 |
[Effect of intraperitoneal therapy in gastric cancer with peritoneal dissemination].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Cisplatin; Female; Humans; Immunity | 1997 |
[A case of gastric cancer with peritonitis carcinomatosa and malignant biliary stenosis treated by intraperitoneal CDDP and MMC with UFT therapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract | 1998 |
Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Combined Modality Therapy; Diagn | 2001 |
[Experimental study of the treatment of carcinomatous peritonitis in gastric cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Infusions, Parente | 1992 |
[Clinical studies on locoregional immunochemotherapy of peritonitis carcinomatosa].
Topics: Cisplatin; Humans; Immunotherapy; Infusions, Parenteral; Mitomycin; Pancreatic Neoplasms; Peritoniti | 1992 |
[Clinical evaluation of intra-peritoneal hyperthermic perfusion under hypothermic general anesthesia for advanced gastric cancer].
Topics: Anesthesia, General; Combined Modality Therapy; Female; Gastrectomy; Humans; Hyperthermia, Induced; | 1991 |
[CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; | 1991 |
[Enhancement of the carcinomatous peritonitis of human gastric cancer by pretreatment of mitomycin C in nude mice: preliminary report].
Topics: Animals; Cell Division; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplan | 1991 |
[Evaluation of intraperitoneal cancer chemotherapy using an implantable reservoir in patients with peritonitis carcinomatosa].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascitic Fluid; Cisplatin; Colorectal Ne | 1990 |
[A case of gastric cancer with peritonitis carcinomatosa which improved upon oral administration of UFT, mitomycin C and lentinan].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; | 1987 |